BackgroundCheck.run
Search For

Keith A Earle, 59115 Embassy Dr, North Wales, PA 19454

Known as:
Keith Anthony Earle Keith A Earz Keith Anthony R Arze E Keith
Related to:
Aloma Earle 82 Keith Packer 59 Edward Lawwell 89 Bob Horton 86

Keith Earle Phones & Addresses

115 Embassy Dr, North Wales, PA 19454    215-5919230   

118 Woodview Ln, North Wales, PA 19454    215-5919547   

6969 Hollister St, Houston, TX 77040    713-4604292   

Philadelphia, PA   

Knoxville, TN   

Brooklyn, NY   

Tuskegee, AL   

Work

Company: D&w fine pack, llc Jan 2013 Position: Quality manager

Education

School / High School: Delaware Valley College 2014 Specialities: MBA in Food & Agribusiness

Skills

Six Sigma Black Belt Certification Certified ISO Internal Auditor Software Systems: Microsoft Office • Minitab • Visio
Get Report
Control this profile

Mentions for Keith A Earle

Career records & work history

License Records

Keith R Earle

Licenses:
License #: RS122054A - Expired
Category: Real Estate Commission
Type: Real Estate Salesperson-Standard

Keith Earle resumes & CV records

Resumes

Keith Earle Photo 35

President

Location:
North Wales, PA
Industry:
Pharmaceuticals
Work:
Teva Pharmaceuticals
Director, Nonclinical Safety Assessment and Drug Development Barr Pharmaceuticals Jul 2003 - Jul 2008
Director, Nonclinical Safety Assessment Millennium Management Services Jul 2003 - Jul 2008
President Cell Pathways Nov 1998 - Jun 2003
Director, Pharmaceutical Product Development Gene Medicine Jul 1994 - Oct 1998
Senior Scientist, Laboratory Animal Medicine and Toxicologist Genetics Institute May 1992 - May 1993
Laboratory Animal Medical Scientist
Education:
Temple University 2011
Master of Science, Masters, Medicine Baylor College of Medicine 1993 - 1996
Doctorates, Medicine Tuskegee University 1993
Tuskegee University 1989
Bachelors, Bachelor of Science, Biology
Skills:
Pharmaceutical Industry, Life Sciences, Biotechnology, Pharmaceutics, Public Speaking, Leadership, Laboratory, Strategic Planning, Research, Team Building, Fda, Clinical Trials, Drug Development, Program Management, Clinical Development, Regulatory Affairs, U.s. Food and Drug Administration
Keith Earle Photo 36

Keith Earle

Keith Earle Photo 37

Keith Earle

Keith Earle Photo 38

Keith Earle - Warminster, PA

Work:
D&W Fine Pack, LLC Jan 2013 to 2000
Quality Manager Schiller Grounds Care - Southampton, PA 2011 to 2012
Quality Engineer McLean Packaging Corporation - Moorestown, NJ 2008 to 2011
Quality Manager MeadWestvaco - Warrington, PA 1993 to 2008
Quality Manager/Process Improvement Manager
Education:
Delaware Valley College 2014
MBA in Food & Agribusiness Holy Family University
Bachelor of Science in Business Administration
Skills:
Six Sigma Black Belt Certification Certified ISO Internal Auditor Software Systems: Microsoft Office, Minitab, Visio

Publications & IP owners

Us Patents

Methods For Treatment Of Cystic Fibrosis

US Patent:
6465494, Oct 15, 2002
Filed:
Aug 24, 2001
Appl. No.:
09/938786
Inventors:
Keith A. Earle - North Wales PA
Hector W. Alila - North Wales PA
Clark M. Whitehead - Warminster PA
W. Joseph Thompson - Doylestown PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A01N 4340
US Classification:
514344, 435196, 514851, 514522, 514307
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of cystic fibrosis.

Methods For Treatment Of Type I Diabetes

US Patent:
6479493, Nov 12, 2002
Filed:
Aug 23, 2001
Appl. No.:
09/935802
Inventors:
Clark M. Whitehead - Warminster PA
Keith A. Earle - North Wales PA
Hector W. Alila - North Wales PA
W. Joseph Thompson - Doylestown PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K 3153
US Classification:
514241, 5142521, 51425506, 514307, 514311, 514357, 514365, 514381, 514394, 514400, 514406, 514419, 514427, 514461, 514866
Abstract:
Substituted condensation products of -benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of type I diabetes.

Methods For Treatment Of Inflammatory Bowel Disease

US Patent:
6699894, Mar 2, 2004
Filed:
Sep 23, 2002
Appl. No.:
10/252286
Inventors:
Keith A. Earle - North Wales PA
Hector W. Alila - North Wales PA
Assignee:
OSI Pharmaceuticals, Inc. - Melville NY
International Classification:
A01N 4340
US Classification:
514357, 514307, 514311, 514381, 514382, 514383, 514365, 514394, 5142521, 424400
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of inflammatory bowel disease.

Methods For Treatment Of Scleroderma

US Patent:
2003007, Apr 17, 2003
Filed:
Aug 23, 2001
Appl. No.:
09/938160
Inventors:
Clark Whitehead - Warminster PA, US
Keith Earle - North Wales PA, US
Hector Alila - North Wales PA, US
W. Joseph Thompson - Doylestown PA, US
International Classification:
A61K031/497
A61K031/53
A61K031/435
A61K031/47
A61K031/415
US Classification:
514/277000, 514/252100, 514/256000, 514/241000, 514/307000, 514/311000, 514/396000, 514/381000, 514/407000, 514/415000, 514/443000
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of scleroderma.

Methods For Treatment Of Lupus Erythematosus

US Patent:
2003007, Apr 17, 2003
Filed:
Aug 23, 2001
Appl. No.:
09/938009
Inventors:
Clark Whitehead - Warminster PA, US
Keith Earle - North Wales PA, US
Hector Alila - North Wales PA, US
W. Thompson - Doylestown PA, US
International Classification:
A61K031/277
A61K031/255
A61K031/195
A61K031/165
US Classification:
514/517000, 514/521000, 514/563000, 514/620000, 514/618000
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of lupus erythematosus.

Methods For Treatment Of Multiple Sclerosis

US Patent:
2003007, Apr 17, 2003
Filed:
May 21, 2002
Appl. No.:
10/152111
Inventors:
Clark Whitehead - Warminster PA, US
Keith Earle - North Wales PA, US
Hector Alila - North Wales PA, US
W. Thompson - Doylestown PA, US
International Classification:
A61K031/277
A61K031/185
A61K031/195
A61K031/165
US Classification:
514/521000, 514/553000, 514/563000, 514/619000, 514/618000
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of multiple sclerosis.

Methods For Treatment Of Rheumatoid Arthritis

US Patent:
2003017, Sep 18, 2003
Filed:
Oct 23, 2002
Appl. No.:
10/278683
Inventors:
Clark Whitehead - Warminster PA, US
Keith Earle - North Wales PA, US
Hector Alila - North Wales PA, US
W. Thompson - Doylestown PA, US
International Classification:
A61K031/00
A61K031/435
US Classification:
514/001000
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of rheumatoid arthritis.

Methods For Treatment Of Scleroderma

US Patent:
2006010, May 11, 2006
Filed:
Dec 15, 2005
Appl. No.:
11/304519
Inventors:
Clark Whitehead - Warminster PA, US
Keith Earle - North Wales PA, US
Hector Alila - North Wales PA, US
W. Thompson - Doylestown PA, US
International Classification:
A61K 31/4965
A61K 31/47
A61K 31/44
US Classification:
514252100, 514256000, 514310000, 514311000, 514357000
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of scleroderma.

Possible Relatives

Cynthia F Earle  David A Earle  Dana B Earle  Debra Earle  Daniel K Earle  Danielle M Earle  Daryl J Earle  Keith A Johnson  Keith J Standish  Keith E Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.